These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12531510)

  • 21. Huntingtin's WW domain partners in Huntington's disease post-mortem brain fulfill genetic criteria for direct involvement in Huntington's disease pathogenesis.
    Passani LA; Bedford MT; Faber PW; McGinnis KM; Sharp AH; Gusella JF; Vonsattel JP; MacDonald ME
    Hum Mol Genet; 2000 Sep; 9(14):2175-82. PubMed ID: 10958656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Huntington's disease: From molecular basis to therapeutic advances.
    Krobitsch S; Kazantsev AG
    Int J Biochem Cell Biol; 2011 Jan; 43(1):20-4. PubMed ID: 21056115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Huntington's disease does not appear to increase the risk of diabetes mellitus.
    Boesgaard TW; Nielsen TT; Josefsen K; Hansen T; Jørgensen T; Pedersen O; Nørremølle A; Nielsen JE; Hasholt L
    J Neuroendocrinol; 2009 Sep; 21(9):770-6. PubMed ID: 19602103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains.
    Modregger J; DiProspero NA; Charles V; Tagle DA; Plomann M
    Hum Mol Genet; 2002 Oct; 11(21):2547-58. PubMed ID: 12354780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microRNA dysregulation in polyglutamine toxicity of TATA-box binding protein is mediated through STAT1 in mouse neuronal cells.
    Roshan R; Choudhary A; Bhambri A; Bakshi B; Ghosh T; Pillai B
    J Neuroinflammation; 2017 Aug; 14(1):155. PubMed ID: 28774347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanded polyglutamine impairs normal nuclear distribution of fused in sarcoma and poly (rC)-binding protein 1 in Huntington's disease.
    Mori S; Honda H; Ishii T; Yoshimura M; Sasagasako N; Suzuki SO; Taniwaki T; Iwaki T
    Neuropathology; 2019 Oct; 39(5):358-367. PubMed ID: 31599037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the Huntington's disease (IT15) protein product in HD patients.
    Schilling G; Sharp AH; Loev SJ; Wagster MV; Li SH; Stine OC; Ross CA
    Hum Mol Genet; 1995 Aug; 4(8):1365-71. PubMed ID: 7581375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid-like inclusions in Huntington's disease.
    McGowan DP; van Roon-Mom W; Holloway H; Bates GP; Mangiarini L; Cooper GJ; Faull RL; Snell RG
    Neuroscience; 2000; 100(4):677-80. PubMed ID: 11036200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Huntingtin and its role in neuronal degeneration.
    Li SH; Li XJ
    Neuroscientist; 2004 Oct; 10(5):467-75. PubMed ID: 15359012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models.
    Tauffenberger A; Chitramuthu BP; Bateman A; Bennett HP; Parker JA
    Hum Mol Genet; 2013 Feb; 22(4):782-94. PubMed ID: 23172908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of corticobasal degeneration and Huntington's disease: can Tau aggregates protect Huntingtin toxicity?
    Caparros-Lefebvre D; Kerdraon O; Devos D; Dhaenens CM; Blum D; Maurage CA; Delacourte A; Sablonnière B
    Mov Disord; 2009 May; 24(7):1089-90. PubMed ID: 19243029
    [No Abstract]   [Full Text] [Related]  

  • 32. Aggregation of expanded huntingtin in the brains of patients with Huntington disease.
    Hoffner G; Souès S; Djian P
    Prion; 2007; 1(1):26-31. PubMed ID: 19172113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Huntington aggregates may not predict neuronal death in Huntington's disease.
    Kuemmerle S; Gutekunst CA; Klein AM; Li XJ; Li SH; Beal MF; Hersch SM; Ferrante RJ
    Ann Neurol; 1999 Dec; 46(6):842-9. PubMed ID: 10589536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Huntingtin protein colocalizes with lesions of neurodegenerative diseases: An investigation in Huntington's, Alzheimer's, and Pick's diseases.
    Singhrao SK; Thomas P; Wood JD; MacMillan JC; Neal JW; Harper PS; Jones AL
    Exp Neurol; 1998 Apr; 150(2):213-22. PubMed ID: 9527890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease.
    Metzger S; Bauer P; Tomiuk J; Laccone F; Didonato S; Gellera C; Mariotti C; Lange HW; Weirich-Schwaiger H; Wenning GK; Seppi K; Melegh B; Havasi V; Balikó L; Wieczorek S; Zaremba J; Hoffman-Zacharska D; Sulek A; Basak AN; Soydan E; Zidovska J; Kebrdlova V; Pandolfo M; Ribaï P; Kadasi L; Kvasnicova M; Weber BH; Kreuz F; Dose M; Stuhrmann M; Riess O
    Hum Genet; 2006 Sep; 120(2):285-92. PubMed ID: 16847693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.
    Steffan JS; Bodai L; Pallos J; Poelman M; McCampbell A; Apostol BL; Kazantsev A; Schmidt E; Zhu YZ; Greenwald M; Kurokawa R; Housman DE; Jackson GR; Marsh JL; Thompson LM
    Nature; 2001 Oct; 413(6857):739-43. PubMed ID: 11607033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Huntington's disease: seeing the pathogenic process through a genetic lens.
    Gusella JF; MacDonald ME
    Trends Biochem Sci; 2006 Sep; 31(9):533-40. PubMed ID: 16829072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation.
    Schaffar G; Breuer P; Boteva R; Behrends C; Tzvetkov N; Strippel N; Sakahira H; Siegers K; Hayer-Hartl M; Hartl FU
    Mol Cell; 2004 Jul; 15(1):95-105. PubMed ID: 15225551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does tissue transglutaminase play a role in Huntington's disease?
    Lesort M; Chun W; Tucholski J; Johnson GV
    Neurochem Int; 2002 Jan; 40(1):37-52. PubMed ID: 11738471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Huntington's disease: from molecular pathogenesis to clinical treatment.
    Ross CA; Tabrizi SJ
    Lancet Neurol; 2011 Jan; 10(1):83-98. PubMed ID: 21163446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.